Corcept Therapeutics Incorporated Financial Ratios — CORT

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-115.44	-78.79	-111.15	- -	- -	27.19	111.15	32.31	29.11	23.7	25.03	23.11	21.05	23.81	15.01
Return on Assets (%)	-99.65	-54.75	-56.72	-64.24	-14.81	13.49	89.27	28.34	26.02	21.55	22.6	20.14	17.62	19.32	11.88
Return on Capital (%)	- -	- -	- -	- -	- -	22.74	- -	32.31	28.96	23.54	24.94	23.07	21.02	23.67	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	22.74	- -	31.27	27.61	22.92	24.82	22.35	18.05	20.02	- -
Gross Margin (%)	- -	97.25	98.62	96.68	97.29	97.47	97.77	97.92	98.2	98.42	98.56	98.66	98.66	98.39	98.3
EBITDA Margin (%)	- -	-1,096.01	-399.94	-103.49	-6.54	12.62	33.27	35.71	37.12	36.86	34.96	28.89	22.73	20.49	6.13
Operating Margin (%)	- -	-1,096.82	-400.66	-104.02	-6.85	12.52	33.2	35.62	36.41	36.23	34.01	28.03	22.24	20.29	5.88
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	43.89	54.8	39.81	40.03	35.02	-30.77	-33.01	-6.65	15.4	-106.7
Pretax Margin (%)	- -	-1,150.53	-444.25	-118.2	-12.74	10.01	33.17	36.68	38.07	37.19	34.16	28.91	25.82	23.92	8.73
Profit Margin (%)	- -	-1,150.53	-444.25	-118.2	-12.74	10.01	81.11	30.01	30.73	29.96	30.74	25.24	22	20.92	13.09
Net Income to Common Margin (%)	- -	-1,150.53	-444.25	-118.2	-12.74	10.01	81.11	30.01	30.73	29.96	30.74	25.24	22	20.92	13.09
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	18.17	19.28	19.45	9.99	12.71	14.79	12.56	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-115.44	-78.79	-111.15	- -	- -	27.19	111.15	32.31	29.11	23.7	25.03	23.11	21.05	23.81	15.01

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	3	6	9	15	15	- -	- -	3	3	1	1	- -	7	6
ST Debt	- -	3	6	9	15	15	- -	- -	2	2	1	1	- -	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	1	- -	- -	- -	6	5
Total Debt/EBITDA	- -	-0.07	-0.14	-0.34	-4.55	1.43	- -	- -	0.03	0.02	- -	0.01	- -	0.05	0.13
Net Debt/EBITDA	1.23	2.49	1.19	0.54	7.75	-3.59	-0.59	-0.46	-0.27	-0.58	-0.61	-0.57	-1.24	-0.92	-2.58
Total Debt/EBIT	- -	-0.07	-0.14	-0.34	-4.35	1.44	- -	- -	0.03	0.02	- -	0.01	- -	0.05	0.14
Net Debt/EBIT	1.23	2.49	1.18	0.54	7.4	-3.62	-0.59	-0.47	-0.28	-0.59	-0.62	-0.59	-1.26	-0.93	-2.69
EBITDA to Interest Expense	-1,293.16	-20.41	-9.17	-7.3	-1.11	5.03	1,080.84	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-1,294.16	-20.49	-9.2	-7.35	-1.11	4.94	1,072.29	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-1,293.28	-20.42	-9.19	-7.34	-1.16	4.99	1,078.67	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	2	5	4	3	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	87.38	62.3	33.32	-9.78	35.64	60.19	86.59	88.51	90.02	91.54	88.68	86.02	81.53	80.85	77.43
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.51	0.1	- -	- -	- -	0.9	0.78
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.51	0.1	- -	- -	- -	0.89	0.77
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.46	0.09	- -	- -	- -	0.73	0.6
Total Debt/Equity (%)	- -	4.29	27.33	-278.16	80.9	35.44	- -	- -	0.93	0.49	0.14	0.23	0.03	1.02	0.94
Total Debt/Capital (%)	- -	4.11	21.46	156.13	44.72	26.17	- -	- -	0.92	0.49	0.14	0.23	0.03	1.01	0.93
Total Debt/Total Assets (%)	- -	2.67	9.1	27.21	28.83	21.33	- -	- -	0.84	0.45	0.12	0.2	0.02	0.83	0.73
Net Debt to Equity	-113.87	-146.3	-233.78	437.54	-137.69	-89.11	-16.27	-15.09	-8.42	-14.56	-20.65	-13.22	-26.75	-18.79	-18.6
Net Debt/Capital (%)	820.94	315.97	174.75	81.4	365.32	-818.11	-19.43	-17.77	-9.11	-16.94	-25.98	-15.19	-36.51	-22.84	-22.59
EBITDA	-32	-36	-41	-27	-3	10	53	90	114	130	128	116	110	138	47
EBITDA-CapEx	-32	-36	-42	-28	-3	10	53	89	113	129	127	116	110	136	46
Operating Income (Loss)	-32	-36	-41	-28	-3	10	53	89	112	128	124	113	107	137	45

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.89	11.13	4.31	1.79	1.94	1.88	3	5.81	7.1	9.28	4.7	5.95	3.52	2.72	2.24
Current Ratio	7.91	11.37	4.58	2.23	2.35	2.4	4.2	6.66	7.91	10.07	5.6	6.89	4.39	3.35	2.92
Quick Ratio	7.89	11.2	4.42	2.03	2.23	2.24	3.95	6.31	7.62	9.83	5.28	6.58	4.05	3.11	2.6
CFO/Avg Current Liab	-6.17	-5.38	-3.51	-2.08	0.18	0.76	2.14	3.55	3.66	3.52	3.53	2	1.43	1.62	0.93
Common Equity/Total Assets	87.38	62.3	33.32	-9.78	35.64	60.19	86.59	88.51	90.02	91.54	88.68	86.02	81.53	80.85	77.43
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.51	0.1	- -	- -	- -	0.9	0.78
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.51	0.1	- -	- -	- -	0.89	0.77
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.46	0.09	- -	- -	- -	0.73	0.6
Total Debt/Equity (%)	- -	4.29	27.33	-278.16	80.9	35.44	- -	- -	0.93	0.49	0.14	0.23	0.03	1.02	0.94
Total Debt/Capital (%)	- -	4.11	21.46	156.13	44.72	26.17	- -	- -	0.92	0.49	0.14	0.23	0.03	1.01	0.93
Total Debt/Total Assets (%)	- -	2.67	9.1	27.21	28.83	21.33	- -	- -	0.84	0.45	0.12	0.2	0.02	0.83	0.73
CFO/Total Liabilities	-545.17	-96.34	-88.11	-72.01	9.37	67.18	206.08	322.98	330.94	314.03	350.14	147.48	110.34	123.19	75.19
CFO/CapEx	-1,096	-238.54	-291.8	-157.33	184.12	94.8	145.43	388.14	125.11	122.75	357.98	291.34	911.37	91.3	672.97
Altman's Z-Score	25.43	-1.32	-3.06	-9.59	2.29	13.71	42.84	27.75	22.56	40.33	29.34	19.02	20.49	22.46	14.34

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	11.87	10.44	11.15	10.53	10.11	12.66	15.28	16.34	15.34	13.6	13.7	13.37	14.2	13.39
Days Sales Outstanding	- -	30.74	34.98	32.73	34.68	36.09	28.84	23.89	22.34	23.79	26.84	26.65	27.31	25.71	27.27
Inventory Turnover	- -	0.21	0.15	0.77	0.94	1.03	1.03	1.12	1.08	1.08	1.07	0.97	0.94	1.08	1.03
Days Inventory Outstanding	- -	1,710.69	2,487.36	476.53	387.39	355.69	354.58	325.74	336.75	337.86	342.05	375.78	389.44	337.8	355.52
Accounts Payable Turnover	- -	0.25	0.12	0.47	1.14	1.5	1.07	0.64	0.78	0.56	0.61	0.69	0.55	0.95	0.48
Accounts Payable Turnover Days	- -	1,433.51	2,924.26	784.22	319.18	243.9	341.94	572.37	465.47	651.46	594.67	530.45	660.88	384.28	758.37
Cash Conversion Cycle	- -	307.91	-401.92	-274.96	102.89	147.88	41.48	-222.75	-106.38	-289.81	-225.77	-128.02	-244.13	-20.77	-375.58
Inventory to Cash Days	- -	-1,679.95	-2,452.38	-443.8	-352.72	-319.6	-325.73	-301.85	-314.41	-314.08	-315.21	-349.13	-362.13	-312.09	-328.25
Inventories	- -	1	1	1	2	2	5	5	5	5	5	6	8	12	13
Raw Materials	- -	3	4	4	2	2	4	4	1	2	- -	- -	- -	- -	1
Work In Process	- -	1	- -	- -	- -	1	- -	6	10	13	11	8	8	8	14
Finished Goods	- -	- -	1	2	2	2	4	6	6	7	6	9	8	8	9
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	288	143	321	304	546	818	2,072	1,537	1,386	3,054	2,098	2,190	3,359	5,297	3,688
- Cash & Cash Equivalents	40	93	55	24	40	52	31	42	31	76	78	66	136	128	120
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	3	6	9	15	15	- -	- -	3	3	1	1	- -	7	6
Enterprise Value	248	52	271	289	521	781	1,983	1,330	1,114	2,616	1,875	1,760	2,991	4,920	3,322
Total Capital	35	64	27	6	33	56	191	276	375	526	376	503	507	687	654
Total Debt/Capital (%)	- -	4.11	21.46	156.13	44.72	26.17	- -	- -	0.92	0.49	0.14	0.23	0.03	1.01	0.93
Total Debt / EV	- -	0.05	0.02	0.03	0.03	0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	15.83	26.2	10.9	10.35	9.61	12.46	5.29	3.63	7.39	5.12	4.38	6.2	7.29	4.36
EV/EBITDA	- -	- -	- -	- -	- -	76.12	37.44	14.82	9.79	20.05	14.65	15.16	27.27	35.58	71.15
EV/EBIT	- -	- -	- -	- -	- -	76.77	37.52	14.86	9.98	20.4	15.06	15.62	27.88	35.93	74.15
EV/Cash Flow to Firm	- -	- -	- -	- -	85.41	38.25	32.48	11.5	8.18	17.21	11.17	14.62	23.61	24.81	23.39
EV/Free Cash Flow to Firm	- -	- -	- -	- -	85.17	37.89	32.26	11.47	8.12	17.07	11.13	14.57	23.58	24.54	23.36
Diluted Market Cap	285	133	320	303	532	843	2,249	1,693	1,483	3,249	2,494	2,355	3,629	5,718	4,176
Diluted Enterprise Value	245	43	271	288	507	806	2,218	1,651	1,455	3,175	2,417	2,290	3,494	5,598	4,061
EV per Share	2.95	0.52	2.72	2.85	4.75	6.93	17.29	11.56	9.72	22.41	17.69	16.32	28.92	46.81	31.35
TTM Sales	- -	3	10	27	50	81	159	251	306	354	366	402	482	675	761
TTM EBITDA	-32	-36	-41	-27	-3	10	53	90	114	130	128	116	110	138	47
TTM Operating Income	-32	-36	-41	-28	-3	10	53	89	112	128	124	113	107	137	45
TTM Cash Flow to Firm	-27	-34	-33	-24	6	20	61	116	136	152	168	120	127	198	142
TTM Free Cash Flow to Firm	-27	-34	-32	-23	6	21	61	116	137	153	168	121	127	200	142

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-10.41	-3.71	-8.68	-11.14	169.14	45.37	36.65	14.6	10.81	21.21	14.81	19.51	28.62	28.52	29.36
EV/EBIT	- -	- -	- -	- -	- -	76.77	37.52	14.86	9.98	20.4	15.06	15.62	27.88	35.93	74.15
Enterprise Value	248	52	271	289	521	781	1,983	1,330	1,114	2,616	1,875	1,760	2,991	4,920	3,322
Low Price	2.51	1.27	1.43	1.69	2.69	3.22	6.7	11.21	9.14	9.7	15.82	16.47	17.86	20.84	32.99
EV/Sales	- -	15.83	26.2	10.9	10.35	9.61	12.46	5.29	3.63	7.39	5.12	4.38	6.2	7.29	4.36
EV/EBITDA	- -	- -	- -	- -	- -	76.12	37.44	14.82	9.79	20.05	14.65	15.16	27.27	35.58	71.15
Price/Earnings	- -	- -	- -	- -	- -	98.61	15.88	20.43	14.69	28.48	20.35	21.39	31.69	36.84	36.27
Price/Earnings Average	-9.55	-7.86	-4.07	-9.75	-80.78	77.42	11.59	24.11	15.12	17.3	23.12	25.01	24.74	25.51	74.23
Price/Earnings High	-13.05	-11.98	-7.03	-14.45	-127.87	135.83	18.26	39.71	21.22	30.24	32.05	31.74	33.44	45.49	122.29
Price/Earnings Low	-6.46	-3.1	-3.1	-5.44	-44.93	43.74	5.89	17.15	11.1	10.56	16.27	17.34	17.43	15.24	34.38
Price/Book Value	8.28	2.31	15.25	-89.78	29.52	19.78	10.85	5.57	3.73	5.84	5.58	4.36	6.63	7.79	5.69
Price/Book Value Average	8.98	5.19	8.92	-90.69	28.71	15.53	7.92	6.57	3.84	3.54	6.34	5.1	5.17	5.4	11.65
Price/Book Value High	12.27	7.92	15.39	-134.38	45.44	27.24	12.48	10.82	5.39	6.2	8.79	6.48	6.99	9.62	19.19
Price/Book Value Low	6.07	2.05	6.79	-50.58	15.97	8.77	4.02	4.67	2.82	2.16	4.46	3.54	3.64	3.22	5.4
Price/Tangible Book Value	8.28	2.31	15.25	-89.78	29.52	19.78	10.85	5.57	3.73	5.84	5.58	4.36	6.63	7.79	5.69
Price/Tangible Book Value Average	8.98	5.19	8.92	-90.69	28.71	15.53	7.92	6.57	3.84	3.54	6.34	5.1	5.17	5.4	11.65
Price/Tangible Book Value High	12.27	7.92	15.39	-134.38	45.44	27.24	12.48	10.82	5.39	6.2	8.79	6.48	6.99	9.62	19.19
Price/Tangible Book Value Low	6.07	2.05	6.79	-50.58	15.97	8.77	4.02	4.67	2.82	2.16	4.46	3.54	3.64	3.22	5.4
Price/Sales	- -	40.22	30.94	11.41	10.59	9.87	12.88	6.13	4.51	8.53	6.26	5.4	6.97	7.71	4.75
Price/Sales Average	- -	90.41	18.1	11.52	10.29	7.75	9.4	7.24	4.64	5.18	7.11	6.31	5.44	5.34	9.72
Price/Sales High	- -	137.82	31.23	17.08	16.29	13.6	14.81	11.92	6.52	9.06	9.85	8.01	7.36	9.52	16
Price/Sales Low	- -	35.72	13.78	6.43	5.73	4.38	4.78	5.15	3.41	3.16	5	4.38	3.83	3.19	4.5
Price/Cash Flow	-10.4	-3.69	-8.65	-11.07	170.06	43.65	33.65	13.32	10.16	19.87	13.64	18.03	26.55	26.23	25.45
Price/Cash Flow Average	-11.28	-8.3	-5.06	-11.18	165.39	34.27	24.57	15.72	10.46	12.07	15.49	21.08	20.73	18.17	52.09
Price/Cash Flow High	-15.42	-12.65	-8.73	-16.56	261.78	60.12	38.7	25.89	14.68	21.1	21.48	26.75	28.02	32.39	85.82
Price/Cash Flow Low	-7.63	-3.28	-3.85	-6.23	91.98	19.36	12.48	11.18	7.68	7.37	10.9	14.62	14.6	10.85	24.13
Price/Free Cash Flow Average	-11.29	-8.34	-5.08	-11.25	164.49	35.62	26.76	17.22	11.12	12.88	16.83	22.81	22.34	19.76	60.09
Price/Free Cash Flow High	-15.43	-12.71	-8.76	-16.67	260.37	62.49	42.15	28.36	15.61	22.52	23.33	28.95	30.2	35.22	99
Price/Free Cash Flow Low	-7.64	-3.29	-3.87	-6.27	91.48	20.12	13.6	12.25	8.16	7.86	11.84	15.82	15.74	11.8	27.84
EV/Sales Average	- -	69.69	13.36	11.01	10.05	7.45	9.31	7.05	4.56	5.03	6.3	6.21	5.16	5.26	9.76
EV/Sales High	- -	120.56	26.49	16.59	16.21	13.41	14.77	11.72	6.44	8.96	8.82	7.93	7.07	9.51	16.18
EV/Sales Low	- -	11	9.04	5.9	5.37	4.01	4.63	4.97	3.33	2.99	4.37	4.26	3.55	3.07	4.44
EV/EBITDA Average	-8.44	-6.36	-3.34	-10.64	-153.76	58.99	27.97	19.74	12.29	13.66	18.02	21.5	22.68	25.65	159.2
EV/EBITDA High	-11.98	-11	-6.62	-16.03	-247.89	106.2	44.4	32.82	17.35	24.3	25.21	27.44	31.09	46.42	263.86
EV/EBITDA Low	-5.31	-1	-2.26	-5.7	-82.07	31.76	13.93	13.91	8.96	8.12	12.5	14.74	15.61	14.97	72.43
EV/EBIT Average	-8.44	-6.35	-3.34	-10.59	-146.83	59.49	28.03	19.8	12.53	13.9	18.52	22.16	23.18	25.9	165.92
EV/EBIT High	-11.98	-10.99	-6.61	-15.95	-236.73	107.11	44.49	32.9	17.69	24.72	25.92	28.28	31.77	46.87	274.99
EV/EBIT Low	-5.31	-1	-2.26	-5.67	-78.38	32.03	13.95	13.94	9.13	8.26	12.85	15.19	15.95	15.11	75.48
Last Price	3.42	1.43	3.21	3	4.98	7.26	18.06	13.36	12.1	26.16	19.8	20.31	32.48	50.39	34.8
High Price	5.07	4.9	3.24	4.49	7.67	10	20.77	25.96	17.48	27.78	31.18	30.14	34.28	62.22	117.33
Enterprise Value Average	273	230	138	292	506	606	1,482	1,772	1,398	1,781	2,306	2,496	2,487	3,548	7,433
Enterprise Value High	387	399	274	440	815	1,090	2,352	2,945	1,975	3,169	3,226	3,185	3,409	6,419	12,319
Enterprise Value Low	172	36	94	157	270	326	738	1,248	1,019	1,059	1,599	1,711	1,711	2,070	3,381

Shares Outstanding	84	100	100	101	110	113	115	115	115	117	106	108	103	105	106
Diluted Weighted Avg Shares	83	93	100	101	107	116	125	127	123	124	126	116	112	113	120
Basic Weighted Avg Shares	83	93	100	101	107	111	114	115	114	115	116	107	104	103	104
Revenue per Share	- -	0.04	0.1	0.26	0.47	0.74	1.4	2.18	2.68	3.07	3.16	3.76	4.66	6.54	7.33
EBITDA per Share	-0.39	-0.39	-0.41	-0.27	-0.03	0.09	0.47	0.78	0.99	1.13	1.11	1.09	1.06	1.34	0.45
Operating Income per Share	-0.39	-0.39	-0.42	-0.27	-0.03	0.09	0.47	0.78	0.98	1.11	1.08	1.05	1.04	1.33	0.43
Basic EPS, GAAP	-0.39	-0.41	-0.46	-0.31	-0.06	0.07	1.14	0.65	0.82	0.92	0.97	0.95	1.02	1.37	0.96
Basic EPS from Cont Ops	-0.39	-0.41	-0.46	-0.31	-0.06	0.07	1.14	0.65	0.82	0.92	0.97	0.95	1.02	1.37	0.96
Diluted EPS, GAAP	-0.39	-0.41	-0.46	-0.31	-0.06	0.07	1.04	0.6	0.77	0.85	0.89	0.87	0.95	1.24	0.83
Diluted EPS from Cont Ops	-0.39	-0.41	-0.46	-0.31	-0.06	0.07	1.04	0.6	0.77	0.85	0.89	0.87	0.95	1.24	0.83
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.33	-0.39	-0.37	-0.27	0.03	0.17	0.54	1	1.19	1.32	1.45	1.13	1.22	1.92	1.37
Free Cash Flow per Basic Share	-0.33	-0.39	-0.37	-0.27	0.03	0.16	0.53	1	1.18	1.31	1.45	1.12	1.22	1.9	1.37
Cash & Equivalents per Share	0.47	0.93	0.55	0.24	0.37	0.46	0.77	1.8	2.41	3.78	2.11	4	3.56	3.65	3.51
Book Value per Share	0.41	0.62	0.21	-0.03	0.17	0.37	1.66	2.4	3.24	4.48	3.55	4.65	4.9	6.47	6.11
Tangible Book Value per Share	0.41	0.62	0.21	-0.03	0.17	0.37	1.66	2.4	3.24	4.48	3.55	4.65	4.9	6.47	6.11

Corcept Therapeutics Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)